Meanwhile, the level of S100A12 also decreased, however not statistically significantly, indicating the predominance of pro-GN and PTX3 assessments in evaluating the beneficial effect of corticosteroid therapy in the course of Crohn’s disease. The gene discussed is PTX3; the disease is ganglioneuroma.